0000000000643846

AUTHOR

Giorgio Milazzo

0000-0002-1930-4763

showing 3 related works from this author

Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: New metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase …

2015

none 7 si Rhodococcus sp. strain BCP1 was initially isolated for its ability to grow on gaseous n-alkanes, which act as inducers for the co-metabolic degradation of low-chlorinated compounds. Here, both molecular and metabolic features of BCP1 cells grown on gaseous and short-chain n-alkanes (up to n-heptane) were examined in detail. We show that propane metabolism generated terminal and sub-terminal oxidation products such as 1- and 2-propanol, whereas 1-butanol was the only terminal oxidation product detected from n-butane metabolism. Two gene clusters, prmABCD and smoABCD—coding for Soluble Di-Iron Monooxgenases (SDIMOs) involved in gaseous n-alkanes oxidation—were detected in the BCP1 g…

Microbiology (medical)Gaseous n-alkaneSoluble di-iron monooxygenaseStrain (chemistry)lcsh:QR1-502Monooxygenase gene expressionMetabolismgaseous n-alkanesMonooxygenaseBiologyLyaseRedoxMicrobiologyPrimer extensionlcsh:MicrobiologyChaperoninRhodococcus sp strain BCP1; soluble di-iron monooxygenase; propane and n-butane oxidation; gaseous n-alkanes; monooxygenase gene expressionBiochemistryRhodococcus sp. strain BCP1Rhodococcus sp strain BCP1Propane and n-butane oxidationGeneOriginal Researchpropane and butane oxidation
researchProduct

Aerobic growth of Rhodococcus aetherivorans BCP1 using selected naphthenic acids as the sole carbon and energy sources

2018

Naphthenic acids (NAs) are an important group of toxic organic compounds naturally occurring in hydrocarbon deposits. This work shows that Rhodococcus aetherivorans BCP1 cells not only utilize a mixture of eight different NAs (8XNAs) for growth but they are also capable of marked degradation of two model NAs, cyclohexanecarboxylic acid (CHCA) and cyclopentanecarboxylic acid (CPCA) when supplied at concentrations from 50 to 500 mgL−1 . The growth curves of BCP1 on 8XNAs, CHCA, and CPCA showed an initial lag phase not present in growth on glucose, which presumably was related to the toxic effects of NAs on the cell membrane permeability. BCP1 cell adaptation responses that allowed survi…

0301 basic medicineMicrobiology (medical)Inclusion bodie030106 microbiologylcsh:QR1-502Settore BIO/19 - Microbiologia Generale7. Clean energyMicrobiologylcsh:Microbiology03 medical and health scienceschemistry.chemical_compoundBiosynthesisRhodococcus aetherivorans naphthenic acids stress response b-oxidation transmission electron microscopy fatty acids methyl esters inclusion bodiesnaphthenic acidsBeta oxidationchemistry.chemical_classificationbiologyStress responseRhodococcus aetherivoranNaphthenic acidCyclohexanecarboxylic acidbiology.organism_classificationRhodococcus aetherivoranschemistryBiochemistryFatty acids methyl esterβ-oxidationfatty acids methyl estersEnergy sourceRhodococcusBacteriaIntracellularTransmission electron microscopyPolyunsaturated fatty acid
researchProduct

A g316a polymorphism in the ornithine decarboxylase gene promoter modulates mycn‐driven childhood neuroblastoma

2021

Simple Summary Neuroblastoma is a devasting childhood cancer in which multiple copies (amplification) of the cancer-causing gene MYCN strongly predict poor outcome. Neuroblastomas are reliant on high levels of cellular components called polyamines for their growth and malignant behavior, and the gene regulating polyamine synthesis is called ODC1. ODC1 is often coamplified with MYCN, and in fact is regulated by MYCN, and like MYCN is prognostic of poor outcome. Here we studied a naturally occurring genetic variant or polymorphism that occurs in the ODC1 gene, and used gene editing to demonstrate the functional importance of this variant in terms of ODC1 levels and growth of neuroblastoma cel…

0301 basic medicineCancer ResearchSNPSingle-nucleotide polymorphismBiologylcsh:RC254-282ArticleOrnithine decarboxylase03 medical and health sciencesneuroblastomaNeuroblastoma0302 clinical medicineNeuroblastomaGenotypeMYCNMedicine and Health SciencesTranscriptional regulationmedicineODC1neoplasmsWild typePromotermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMolecular biology030104 developmental biologyOncology030220 oncology & carcinogenesisChildhood Neuroblastoma
researchProduct